GL1X · GenesisL1 explorer

Research workbench

Crystal Structure of human cyclic GMP-AMP synthase in complex with 5-bromo-N-[[2-fluoro-5-(1-methylpyrazol-4-yl)phenyl]methyl]-2-hydroxybenzamide

Analyse Crystal Structure of human cyclic GMP-AMP synthase in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7FTT
Type
protein
Length
691 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.235
Source
Homo sapiens
Molecule
Cyclic GMP-AMP synthase
EC
2.7.7.86
UniProt
Q8N884
Ligands
YPU, ZN
Pockets
5 · best druggability 0.80

Structure

x-ray diffraction · resolution 2.235 · 2 distinct chains · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclic GMP-AMP synthase (EC 2.7.7.86)protein34346% helix, 17% strandQ8N884
BCyclic GMP-AMP synthase (EC 2.7.7.86)protein34844% helix, 17% strandQ8N884

Ligands and binding sites

  • YPU · 5-bromo-N-{[(5P)-2-fluoro-5-(1-methyl-1H-pyrazol-4-yl)phenyl]methyl}-2-hydroxybenzamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19950.800.8184YPU
211320.780.8088YPU
32100.600.8124empty
4940.340.7424empty
5630.330.7716empty

Interfaces

1 interface between chains.

  • A–B · 766 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • Q8N884 · AlphaFold monomer V2.0 prediction for cyclic gmp-AMP synthase (Q8N884) · a predicted model of the same protein · chain B against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.